Results 261 to 270 of about 15,400,316 (399)

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.

Journal of Clinical Oncology, 2008
Steven J. Cohen, C. Punt, N. Iannotti, B. Saidman, K. Sabbath, N. Gabrail, J. Picus, M. Morse, E. Mitchell, M. Miller, G. Doyle, H. Tissing, L. Terstappen, Neal J. Meropol   +13 more
semanticscholar   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Significance and Correlation Analysis of Folate Receptor-Positive Circulating Tumor Cells (FR + CTC) in Colorectal Cancer Patients. [PDF]

Cancer Rep (Hoboken)
Hu R, Lan A, Li D, Liu C.
europepmc   +1 more source

Tumor lysis syndrome from a solitary nonseminomatous germ cell tumor [PDF]

, 2017
Brandon Nokes, Rodrigo Cartin‐Ceba, Joseph C. Farmer, Alyssa Chapital   +3 more
openalex   +1 more source

Isolation of circulating tumor cells using a microvortex-generating herringbone-chip

Proceedings of the National Academy of Sciences of the United States of America, 2010
Shannon L. Stott, Chia-Hsien Hsu, Chia-Hsien Hsu, Chia-Hsien Hsu, D. Tsukrov, Min Yu, D. Miyamoto, B. A. Waltman, S. Rothenberg, Ajay M Shah, Malgorzata E. Smas, George K Korir, Frederick P. Floyd, A. Gilman, Jenna B Lord, D. Winokur, S. Springer, D. Irimia, D. Irimia, S. Nagrath, S. Nagrath, L. Sequist, L. Sequist, Richard J. Lee, Richard J. Lee, K. Isselbacher, S. Maheswaran, D. Haber, D. Haber, Mehmet Toner, Mehmet Toner   +30 more
semanticscholar   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

Molecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller, Susanne Ebner, Carmen Haselrieder, Julia K. Günther, Astrid Drasche, Sophie Strich, Chiara Volani, Andrea Medici, Aleksandar Nikolajevic, Alex Deltedesco, Johannes E. Sigmund, Michael J. Blumer, Martin Hermann, Johanna Vanacker, Gerald Brandacher, Eduard Stefan, Omar Torres‐Quesada, Jakob Troppmair   +17 more
wiley   +1 more source

Breast cancer stem cells and circulating tumor cells: Dual drivers of progression and relapse. [PDF]

World J Stem Cells
Azizi Z, Er Urganci B, Acikbas I.
europepmc   +1 more source

Short DNA sequences from the cytoplasm of mouse tumor cells induce immortalization of human lymphocytes in vitro.

, 1993
Hinrich Abken, R Hegger, C Bützler, K. Willecke   +3 more
openalex   +2 more sources

Arginine dependence of tumor cells: targeting a chink in cancer’s armor

Oncogene, 2016
M. Patil, Jayeeta Bhaumik, Suboj Babykutty, U. Banerjee, D. Fukumura   +4 more
semanticscholar   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

Molecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad, Marie Austdal, Oddmund Nordgård, Gunnar Mellgren, Satu Oltedal, Marie L. Austbø, Ylva H. Vignes, Thomas Helland, Kristin Jonsdottir, Tone H. Lende, Emilius A. M. Janssen, Bjørnar Gilje, Kjersti Tjensvoll, PBCB study group, Gunnar Mellgren, Tone Hoel Lende, Anette Heie, Kristin Viste, Anita Røyneberg Alvheim, Emiel AM Janssen, Kristin Jonsdottir, Ann Cathrine Kroksveen, Thomas Helland, Einar Gudlaugsson, Oddmund Nordgård, Satu Oltedal, Kristin Løge Aanestad, Jan Terje Kvaløy, Kirsten Lode, Kari Britt Hagen, Marie Austdal, Ylva H. Vignes, Siri Tungland Sola, Nina Egeland Amundsen, Finn Magnus Eliassen, Emeritus Ernst A Lien   +35 more
wiley   +1 more source